These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 437835)

  • 21. The in vitro and in vivo effects of metronidazole and chloroquine on Trypanosoma brucei brucei.
    Otigbuo IN; Woo PT
    J Parasitol; 1988 Apr; 74(2):201-6. PubMed ID: 3357110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphocyte function in experimental African trypanosomiasis. V. Role of antibody and the mononuclear phagocyte system in variant-specific immunity.
    Dempsey WL; Mansfield JM
    J Immunol; 1983 Jan; 130(1):405-11. PubMed ID: 6847889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Murine T lymphocyte specificity for African trypanosomes. II. Suppression of the T lymphocyte proliferative response to Trypanosoma brucei by systemic trypanosome infection.
    Gasbarre LC; Hug K; Louis J
    Clin Exp Immunol; 1981 Jul; 45(1):165-72. PubMed ID: 6458434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A longitudinal study of the susceptibility to normal human serum of a Trypanosoma brucei rhodesiense clone non-cyclically passaged in rats.
    Rickman LR
    East Afr Med J; 1984 Aug; 61(8):596-9. PubMed ID: 6535712
    [No Abstract]   [Full Text] [Related]  

  • 25. [Behavior of a Trypanosoma brucei strain (STIB 348C) in mice. 3. Histopathological findings in the terminal stage of infection].
    Büngener W
    Tropenmed Parasitol; 1983 Dec; 34(4):213-9. PubMed ID: 6665866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune depression in Trypanosoma brucei brucei infected mice. Sequential histological and immunological findings.
    Martinotti MG; Forni M; Del Monte AM; Giovarelli M; Forni G; Landolfo S
    Boll Ist Sieroter Milan; 1981; 60(4):288-96. PubMed ID: 6173044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of anti-ganglioside antibody in experimental Trypanosoma brucei infection in mice.
    Tsujimura Y; Watarai S; Uemura A; Ohnishi Y; Kodama H
    Res Vet Sci; 2005 Jun; 78(3):245-7. PubMed ID: 15766944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New fluorescence markers to distinguish co-infecting Trypanosoma brucei strains in experimental multiple infections.
    Balmer O; Tostado C
    Acta Trop; 2006 Jan; 97(1):94-101. PubMed ID: 16212925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebral trypanosomiasis in cattle with mixed Trypanosoma congolense and T. brucei brucei infections.
    Masake RA; Nantulya VM; Akol GW; Musoke AJ
    Acta Trop; 1984 Sep; 41(3):237-46. PubMed ID: 6150618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trypanosoma congolense infections: antibody-mediated phagocytosis by Kupffer cells.
    Shi M; Wei G; Pan W; Tabel H
    J Leukoc Biol; 2004 Aug; 76(2):399-405. PubMed ID: 15136584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet-aggregating activity of released factor(s) from Trypanosoma brucei brucei.
    Nwagwu M; Inyang AL; Molokwu RI; Essien EM
    Afr J Med Med Sci; 1989 Dec; 18(4):283-7. PubMed ID: 2558559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tsetse fly saliva accelerates the onset of Trypanosoma brucei infection in a mouse model associated with a reduced host inflammatory response.
    Caljon G; Van Den Abbeele J; Stijlemans B; Coosemans M; De Baetselier P; Magez S
    Infect Immun; 2006 Nov; 74(11):6324-30. PubMed ID: 16954393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Defense mechanisms in trypanosomiasis].
    Daulouede PS; Okomo-Assoumou MC; Labassa M; Fouquet C; Vincendeau P
    Bull Soc Pathol Exot; 1994; 87(5):330-2. PubMed ID: 7496195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innate resistance to experimental African trypanosomiasis: differences in cytokine (TNF-alpha, IL-6, IL-10 and IL-12) production by bone marrow-derived macrophages from resistant and susceptible mice.
    Kaushik RS; Uzonna JE; Zhang Y; Gordon JR; Tabel H
    Cytokine; 2000 Jul; 12(7):1024-34. PubMed ID: 10880248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surface coat variant antigen of Trypanosoma brucei brucei: its clearance from blood and concentration in organs of normal, infected, and immune mice.
    Diffley P; Jayawardena AN
    Infect Immun; 1982 Jan; 35(1):173-8. PubMed ID: 6119292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxicity of monoclonal antibodies to Trypanosoma brucei.
    Crowe JS; Lamont AG; Barry JD; Vickerman K
    Trans R Soc Trop Med Hyg; 1984; 78(4):508-13. PubMed ID: 6207646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune mechanisms in C57B1 mice genetically resistant to Trypanosoma congolense infection. II. Aspects of the humoral response.
    MacAskill JA; Holmes PH; Whitelaw DD; Jennings FW; Urquhart GM
    Parasite Immunol; 1983 Nov; 5(6):577-86. PubMed ID: 6657296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophages as primary target cells and mediators of immune dysfunction in African trypanosomiasis.
    Grosskinsky CM; Askonas BA
    Infect Immun; 1981 Jul; 33(1):149-55. PubMed ID: 6114926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrastructural and immunological aspects of the phagocytosis of Trypanosoma brucei by mouse peritoneal macrophages.
    Stevens DR; Moulton JE
    Infect Immun; 1978 Mar; 19(3):972-82. PubMed ID: 640740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surface phagocytosis of Trypanosoma brucei.
    Cook RM
    Trans R Soc Trop Med Hyg; 1978; 72(5):554-5. PubMed ID: 726010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.